In 2023, the pharmaceutical company reported positive feedback after Phase 2 testing of the drug. It found that after 24 weeks, participants with obesity or those overweight (without diabetes ...

In the race to find Ozempic 2.0, a few stand-outs are emerging. While GLP-1 drugs have paved the way for a new era of healthcare, they have some drawbacks. They need to be injected (a draw-back ...

Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and ...

There have been numerous reports on social media platforms like TikTok and Instagram where women have shared experiences of ...

A drug for treating diabetes similar to popular weight-loss medicines such as Ozempic did not show any benefits for people ...

The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a ...

A popular diabetes drug just got a major new approval—and it could be a game-changer for millions of Americans at risk for ...

Approval was based on results from the Phase IIIb FLOW trial, which demonstrated a 24% relative risk reduction in kidney ...

Ozempic, or semaglutide, can now be used to reduce the risk of worsening kidney disease or kidney failure in adults with type ...